Axsome Therapeutics, Inc. (AXSM) stock analysis

In our weekly check, Axsome Therapeutics, Inc. is graded C (A to F). Of 22 checks on debt, profit, cash flow and trend: 12 pass, warnings: 2, red flags: 8.

About Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as AXSM.

What our checks show for AXSM

Red flags

Warning signs

Strengths

Similar companies

TWST · ABVX · ORKA · CYTK · IMVT · TXG

Questions

What grade does Axsome Therapeutics, Inc. (AXSM) have?

In our weekly check, Axsome Therapeutics, Inc. is graded C (A to F). Of 22 checks on debt, profit, cash flow and trend: 12 pass, warnings: 2, red flags: 8. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of AXSM stock?

This week's biggest flags for Axsome Therapeutics, Inc.: Weak interest cover, Margins falling, Weak EPS growth. In total 10 of 22 checks show a warning or a red flag.

What does Axsome Therapeutics, Inc. do?

Axsome Therapeutics, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as AXSM.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis